Vimarsana
Biggest News Aggregation in the World

Pulsus Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pulsus Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pulsus Group Today - Breaking & Trending Today

PM Modi's intervention sought to restore backward castes deleted from T'gana OBC list - Vimarsana News

PM Modi's intervention sought to restore backward castes deleted from T'gana OBC list

Backward classes leader Gedela Srinubabu has urged Prime Minister Narendra Modi to restore 26 backward castes deleted from the OBC list in Telangana.Srinubabu, who is the CEO of Pulsus Group, met the Prime Minister during his visit to Hyderabad ...

Sustainability: 'India will become AI -Powered manufacturing hub' - Vimarsana News

Sustainability: 'India will become AI -Powered manufacturing hub'

India Business News: The Co-Convenor of the G20 Health, Pharma, and Tech Summit Series, Dr. Gedela Srinubabu emphasized the growing demand for Artificial Intelligence (AI)

Mainz Biomed N.V. (MYNZ) Stock: Evaluating the Annual Growth - Vimarsana News

Mainz Biomed N.V. (MYNZ) Stock: Evaluating the Annual Growth

The stock of Mainz Biomed N.V. (MYNZ) has gone down by 0.00% for the week, with a -22.83% drop in the past month and a -47.83% drop in the past quarter. The volatility ratio for the week is 13.92%, and the volatility levels for the past 30 days are 10.21% for MYNZ. The simple moving average for the

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology - Vimarsana News

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology

Issuer: Mainz BioMed N.V. / Key word: Conference/Study results Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on...

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology - Mainz Biomed (NASDAQ:MYNZ) - Vimarsana News

Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology - Mainz Biomed (NASDAQ:MYNZ)

Clinical trial evaluating the Company's novel mRNA biomarkers demonstrated sensitivity for colorectal cancer of 94% with specificity of 97% and advanced adenoma sensitivity of 81%Pulsus Group's 4th International